Argitalpenak (41) ROGELIO GARCÍA CENTENO argitalpenak

2024

  1. Adenomas hipofisarios y adenomas funcionantes

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 14, Núm. 16, pp. 933-946

  2. Differences in the clinical and hormonal presentation of patients with familial and sporadic primary aldosteronism

    Frontiers in Endocrinology, Vol. 15

  3. ERRATUM: Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs

    Endocrine-related cancer

  4. Glucose metabolism outcomes after pituitary surgery in patients with acromegaly

    Pituitary, Vol. 27, Núm. 5, pp. 497-506

  5. High prevalence of venous thrombotic events in Cushing’s syndrome: data from ERCUSYN and details in relation to surgery

    European Journal of Endocrinology, Vol. 190, Núm. 1, pp. 75-85

  6. Is adrenal venous sampling always necessary to differentiate between unilateral and bilateral primary aldosteronism? Lesson from the SPAIN-ALDO register

    Endocrine, Vol. 84, Núm. 2, pp. 683-693

  7. Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs

    Endocrine-Related Cancer, Vol. 31, Núm. 7

  8. Protocolo diagnóstico de la hiperprolactinemia

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 14, Núm. 16, pp. 970-974

  9. Protocolo diagnóstico del hirsutismo

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 14, Núm. 17, pp. 1030-1033

  10. Protocolo diagnóstico del síndrome de la silla turca vacía

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 14, Núm. 16, pp. 975-978

  11. Risk factors for intraoperative hypertensive crisis in patients with pheochromocytomas and sympathetic paragangliomas

    Journal of Hypertension, Vol. 42, Núm. 2, pp. 252-259

  12. Robotic and Laparoscopic Adrenalectomy for Pheochromocytoma: An International Multicenter Study

    European Urology Focus

  13. Síndrome de secreción inadecuada de hormona antidiurética

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 14, Núm. 17, pp. 994-1003

2023

  1. An Integrated CT and MRI Imaging Model to Differentiate between Adrenal Adenomas and Pheochromocytomas

    Cancers, Vol. 15, Núm. 14

  2. Autonomous cortisol secretion in patients with primary aldosteronism: prevalence and implications on cardiometabolic profile and on surgical outcomes

    Endocrine Connections, Vol. 12, Núm. 9

  3. Differences in intraoperative and surgical outcomes between normotensive pheochromocytomas and sympathetic paragangliomas (PPGLs) and hypertensive PPGLs: results from the PHEO-RISK STUDY

    Journal of Endocrinological Investigation, Vol. 46, Núm. 4, pp. 805-814

  4. Effect of Obesity on Clinical Characteristics of Primary Aldosteronism Patients at Diagnosis and Postsurgical Response

    The Journal of clinical endocrinology and metabolism, Vol. 109, Núm. 1, pp. e379-e388

  5. Efficacy and safety of temozolomide in the treatment of aggressive pituitary neuroendocrine tumours in Spain

    Frontiers in Endocrinology, Vol. 14

  6. Genetic Study in Pheochromocytoma: Is It Possible to Stratify the Risk of Hereditary Pheochromocytoma?

    Neuroendocrinology, Vol. 113, Núm. 6, pp. 657-666

  7. Local recurrence and metastatic disease in pheochromocytomas and sympathetic paragangliomas

    Frontiers in Endocrinology, Vol. 14